Halvtidsseminarier Halvtidskontroll: Fredrik Sundquist

2024-05-16 13:00 Add to iCal
KBH Konferensrum W8

The use of somatostatin analogues and somatostatin receptor-based targeted radiotherapy to suppress re-growth and deplete metastatic disease in high-risk neuroblastoma.

Handledare

Jakob Stenman, MD., Docent. Childhood Cancer Research Unit, Division of Pediatric Oncology and Surgery, Department of Women's and Children's Health, Karolinska Institutet, Stockholm

Bi-handledare

Per Kogner, MD., Professor. Childhood Cancer Research Unit, Division of Pediatric Oncology and Surgery, Department of Women's and Children's Health, Karolinska Institutet, Stockholm

Malin Wickström, Docent, Childhood Cancer Research Unit, Division of Pediatric Oncology and Surgery, Department of Women's and Children's Health, Karolinska Institutet, Stockholm

Nikolas Herold, MD, Docent, Childhood Cancer Research Unit, Division of Pediatric Oncology and Surgery, Department of Women's and Children's Health, Karolinska Institutet, Stockholm

Halvtidskommitté

Daniel Bexell, MD, Docent. Molekylär barnonkologi, Avdelningen för translationell cancerforskning, Institutionen för laboratoriemedicin, Lunds Universitet 

Trond Flaegstad, MD, Professor. Barneonkologi, Research group for Child and Adolescents Health,  Tromsö Universitet

Katarzyna Fröss-Baron, MD, PhD. Institutionen för medicinska vetenskaper, Endokrin tumörbiologi, Uppsala Universitet

 

Kontakt

Fredrik Sundquist Doktorand